Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(2)
American Journal of Therapeutics(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Current Hypertension Reports(1)
F1000Research(1)
Área temáticas
Enfermedades(6)
Farmacología y terapéutica(3)
Fisiología humana(2)
Salud y seguridad personal(2)
Bioquímica(1)
Origen
scopus(6)
Approach to a successful selection of antihypertensive drugs for the patient with atherosclerosis
ArticleAbstract: Coronary heart disease has become a medical and public health issue associated with multiple risk faPalabras claves:ACE inhibitors, atherosclerosis, Coronary heart disease, Hypertension, myocardial infarctionAutores:Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusPrevalence, awareness, management of hypertension and association with metabolic abnormalities: The Maracaibo city metabolic syndrome prevalence study
ArticleAbstract: Background: The purpose of this study was to determine the prevalence and epidemiologic behavior ofPalabras claves:Arterial hypertension, Cardiovascular disease, diabetes mellitus, Latin America, obesity, PREVALENCEAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Calvo M.J., Gómez M.C., González M.C., Gonzalez R., Israili Z.H., Lopez-Miranda J., Lubo A., Martínez M.S., Olivar L.C., Rojas E.R., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopusTargeting hypertension in patients with cardiorenal metabolic syndrome
ReviewAbstract: Diabetes mellitus coexisting with hypertension is greater than chance alone would pbkp_redict. HyperPalabras claves:Antihypertensive therapy, Blood pressure, Cardiorenal metabolic syndrome, DIABÉTES, Hypertension, Kidney disease, Pharmacologic therapy, RAAS, Reninangiotensin- aldosterone systemAutores:Bolli P., Israili Z.H., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopus